Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,301 to 2,320 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia. | Leuk Res | 2018 | 29306105 | PubTator, text mining | PubMed |
| Aging and the rise of somatic cancer-associated mutations in normal tissues. | PLoS Genet | 2018 | 29300727 | PubTator, text mining | PubMed |
| Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR. | Int J Oncol | 2018 | 29286103 | PubTator, text mining | PubMed |
| Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21). | Int J Hematol | 2018 | 29264741 | PubTator, text mining | PubMed |
| Time course gene expression data in colon of mice after exposure to food-grade E171. | Data Brief | 2018 | 29264374 | PubTator, text mining | PubMed |
| A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells. | Leuk Lymphoma | 2018 | 29249175 | PubTator, text mining | PubMed |
| AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer. | J Cell Biochem | 2018 | 29236325 | PubTator, text mining | PubMed |
| The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. | Nat Med | 2018 | 29227476 | PubTator, text mining | PubMed |
| Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo. | Biochem Pharmacol | 2018 | 29208365 | PubTator, text mining | PubMed |
| Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study. | Leuk Res | 2018 | 29175379 | PubTator, text mining | PubMed |
| Isolated Pancreatic Myeloid Sarcoma Associated with t(8;21)/RUNX1-RUNX1T1 Rearrangement. | Intern Med | 2018 | 29151502 | PubTator, text mining | PubMed |
PCB exposure and potential future cancer incidence in Slovak children: an assessment from molecular finger printing by Ingenuity Pathway Analysis (IPA®) derived from experimental and epidemiological investigations. | Environ Sci Pollut Res Int | 2018 | 29143255 | PubTator, text mining | PubMed |
| Simultaneous occurrence of two distinct leukemic clones with PML-RARα and RUNX1-RUNX1T1 in a case of acute myeloid leukemia. | Ann Hematol | 2018 | 29124313 | PubTator, text mining | PubMed |
| Outcomes of Patients With Relapsed Core Binding Factor-Positive Acute Myeloid Leukemia. | Clin Lymphoma Myeloma Leuk | 2018 | 29107583 | PubTator, text mining | PubMed |
| Multiplex fusion gene testing in pediatric acute myeloid leukemia. | Pediatr Int | 2018 | 29105243 | PubTator, text mining | PubMed |
| Chimeric RNAs and their implications in cancer. | Curr Opin Genet Dev | 2018 | 29100211 | PubTator, text mining | PubMed |
| Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia. | Leukemia | 2018 | 29089646 | PubTator, text mining | PubMed |
| Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia. | Pediatr Int | 2018 | 29067751 | PubTator, text mining | PubMed |
| RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins. | J Cell Biochem | 2018 | 29052866 | PubTator, text mining | PubMed |
| A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia. | Br J Haematol | 2018 | 28961307 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=116